Monitoring of cytomegalovirus reactivation in bone marrow transplant recipients by real-time PCR

Pathology and Oncology Research

Volumn 14, Issue 4, 2008, Pages 399-409

  Ghaffari, Seyed H ^a   Obeidi, Narghes ^b   Dehghan, Mehdi ^a   Alimoghaddam, Kamran ^a   Gharehbaghian, Ahmad ^b   Ghavamzadeh, Ardashir ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b IRANIAN BLOOD TRANSFUSION ORGANIZATION   (Iran)

Author keywords

Cyclosporins; Cytomegalovirus; Pp65 antigenemia; Real time PCR; TaqMan

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUDARABINE; GANCICLOVIR; VIRUS DNA;

ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; BONE MARROW TRANSPLANTATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DRUG BLOOD LEVEL; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN TISSUE; IMMUNOASSAY; INTERMETHOD COMPARISON; LEUKOCYTE; MAINTENANCE THERAPY; MALE; REAL TIME POLYMERASE CHAIN REACTION; SCHOOL CHILD; VIRUS LOAD; VIRUS REACTIVATION;

ADOLESCENT; ADULT; ANTIVIRAL AGENTS; BONE MARROW TRANSPLANTATION; CHILD; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; FEMALE; GANCICLOVIR; HUMANS; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VIRUS ACTIVATION;

EID: 60049100538     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12253-008-9030-3     Document Type: Article

References (48)

1. Boeckh M, Boivin G (1998) Quantitation of cytomegalovirus: methodologic aspects and clinical applications. Clin Microbiol Rev 11:533-554
2. Salzberger B, Bowden RA, Hackman R et al (1997) Neutropenia in allogeneic marrow transplant recipients receiving ganciclovirfor prevention of CMV disease: risk factors and outcome. Blood 90: 2502-2508
3. Li CR, Greenberg PD, Gilbert MJ et al (1994) Recovery of HLA- restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxis. Blood 83:1971-1979
4. Goodrich JM, Bowden RA, Fisher L et al (1993) Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant. Ann Intern Med 118:173-178
5. Winston DJ, Ho WG, Bartoni K et al (1999) Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients. Results of a placebo- controlled, double-blind trial. Ann Intern Med 118:179-184
6. Goodrich JM, Mori M, Gleaves CA et al (1991) Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation. N Engl J Med 325:1601-1607
7. Schmidt GM, Horak DA, Niland JC et al (1991) A randomized controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants. N Engl J Med 324:1005-1011
8. Aitken CW, Barrett-Muir C, Millar K et al (1999) Use of molecular assays in diagnosis and monitoring of cytomegalovirus disease following renal transplantation. J Clin Microbiol 37:2804- 2807
9. Griscelli F, Barrois M, Chauvin S et al (2001) Quantification of human cytomegalovirus DNA in bone marrow transplant recipients by real-time PCR. J Clin Microbiol 39:4362-4369
10. Gleaves CA, Smith TH, Shuster EA et al (1984) Rapid detection of cytomegalovirus in MRC-5 cells inoculated with urine specimens by using low-speed centrifugation and monoclonal antibody to an early antigen. J Clin Microbiol 19:917-919
11. Boeckh M, Gooley TA, Myerson D et al (1996) Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study. Blood 10:4063-4071
12. Hebart H, Gamer D, Loeffer J et al (1998) Evaluation of Murex CMV DNA hybrid capture assay for the detection and quantification of cytomegalovirus infection in patients following allogeneic stem cell transplantation. J Clin Microbiol 36:1333-1337
13. Einsele H, Steidle M, Vallbracht A et al (1991) Early occurrence of human cytomegalovirus infection after bone marrow transplantation as demonstrated by the polymerase chain reaction technique. Blood 77:1104-1110
14. Gault E, Miche Y, Dehe'e A et al (2001) Quantification of human cytomegalovirus DNA by real-time PCR. J Clin Microbiol 39: 772-775
15. Machida U, Kami M, Fukui T et al (2000) Real-time automated PCR for early diagnosis and monitoring of cytomegalovirus infection after bone marrow transplantation. J Clin Microbiol 38: 2536-2542
16. Mori T, Okamoto S, Matsuoka S et al (2000) Risk-adapted preemptive therapy for cytomegalovirus disease in patients undergoing allogeneic bone marrow transplantation. Bone Marrow Transplant 25:765-769
17. Nitsche A, Steuer N, Schmidt CA et al (2000) Detection of human cytomegalovirus DNA by real-time quantitative PCR. J Clin Microbiol 38:2734-2737
18. Razonable RR, Brown RA, Espy MJ et al (2001) Comparative quantification of cytomegalovirus (CMV) DNA in solid-organ transplant recipients with CMV infection by using two high- throughput automated systems. J Clin Microbiol 39:4472-4476
19. Schaade L, Kockelkorn P, Ritter K et al (2000) Detection of cytomegalovirus DNA in human specimens by lightCycler PCR. J Clin Microbiol 38:4006-4009
20. Tanaka N, Kimura H, Iida K et al (2000) Quantitative analysis of cytomegalovirus load using a real-time PCR assay. J Med Virol 60:455-462
21. Yun Z, Lewensohn-Fuchs I, Ljungman P et al (2000) Real-time monitoring of cytomegalovirus infections after stem cell transplantation using the TaqMan polymerase chain reaction assays. Transplantation 69:1733-1736
22. Yakushiji K, Gondo H, Kamezaki K et al (2002) Monitoring of cytomegalovirus reactivation after allogeneic stem cell transplantation: comparison of an antigenemia assay and quantitative real-time polymerase chain reaction. Bone Marrow Transplant 29:599-606
23. Leruez-Ville M, Ouachee M, Delarue R et al (2003) Monitoring cytomegalovirus infection in adult and pediatric bone marrow transplant recipients by a real-time PCR assay performed with blood plasma. J Clin Microbiol 41:2040-2046
24. Tanabe K, Tokumoto T, Ishikawa N et al (1997) Comparative study of cytomegalovirus (CMV) antigenemia assay, polymerase chain reaction, serology, and shell vial assay in the early diagnosis and monitoring of CMV infection after renal transplantation. Transplantation 64:1721-1725
25. Seropian S, Ferguson D, Salloum E et al (1998) Lack of reactivity to CMV pp65 antigenemia testing in a patient with CMV disease following allogeneic bone marrow transplant. Bone Marrow Transplant 22:507-509
26. Solano C, Munoz I, Gutierrez A et al (2001) Qualitative plasma PCR Assay (AMPLICOR CMV Test) versus pp65 antigenemia assay for monitoring cytomegalovirus viremia and guiding preemptive ganciclovir therapy in allogeneic stem cell transplantation. J Clin Microbiol 39:3938-3941
27. Ljungman P, Plotkin S (1995) Workshop on CMV disease- definitions, clinical severity scores and new syndromes. Scand J Infect Dis Suppl 99:87-89
28. Przepiorka D, Weisdorf D, Martin P et al (1994) Consensus conference on Acute GVHD grading. Bone Marrow Transplant 15:825-828
29. Jabs DA, Forman M, Enger C et al (1999) Comparison of cytomegalovirus loads in plasma and leukocytes of patients with cytomegalovirus retinitis. J Clin Microbiol 37:1431-1435
30. Pellegrin I, Garrigue I, Ekouevi D et al (2000) New molecular assays to predict occurrence of cytomegalovirus disease in renal transplant recipients. J Infect Dis 182:36-42
31. Schafer P, Tenschert W, Cremaschi L, et al (2001) Area under the viraemia curve versus absolute viral load: utility for predicting symptomatic cytomegalovirus infections in kidney transplant patients. J Med Virol 65:85-89
32. Boeckh M, Hawkins G, Myerson D et al (1997) Plasma PCR for cytomegalovirus DNA after allogeneic marrow transplantation: comparison with PCR using peripheral blood leukocytes, pp65 antigenemia and viral culture. Transplantation 64:108-113
33. Ksouri H, Eljed H, Greco A et al (2007) Analysis of cytomegalovirus (CMV) viremia using the pp65 antigenemia assay, the amplicor CMV test, and a semi- quantitative polymerase chain reaction test after allogenic marrow transplantation. Transpl Infect Dis 9:16-21
34. Garrigue I, Boucher S, Couzi L et al (2006) Whole blood realtime quantitative PCR for cytomegalovirus infection follow-up in transplant recipients. J Clin Virol 36:72-75
35. Mhiri L, Kaabi B, Houimel M, Arrouji Z, Slim A (2007) Comparison of pp65 antigenemia, quantitative PCR and DNA hybrid capture for detection of cytomegalovirus in transplant recipients and AIDS patients. J Virol Methods 143:23-28
36. Schvoerer E, Henriot S, Zachary P et al (2005) Monitoring low cytomegalovirus viremia in transplanted patients by a real-time PCR on plasma. J Med Virol 76:76-81
37. Martin-Davila P, Fortun J, Gutierrez C et al (2005) Analysis of a quantitative PCR assay for CMV infection in liver transplant recipients: an intent to find the optimal cut-off value. J Clin Virol 33: 138-144
38. Gouarin S, Vabret A, Gault E et al (2004) Quantitative analysis of HCMV DNA load in whole blood of renal transplant patients using real-time PCR assay. J Clin Virol 29:194-201
39. Li H, Dummer S, Estes WR, et al (2003) Measurement of human cytomegalovirus loads by quantitative real-time PCR for monitoring clinical intervention in transplant recipients. J Clin Microbiol 41:187-191
40. Mengelle C, Sandres-Saun'e K, Pasquier C et al (2003) Automated extraction and quantification of human cytomegalovirus DNA in whole blood by real-time PCR assay. J Clin Microbiol 41:3840-3845
41. Guiver M, Fox AJ, Mutton K, Mogulkoc N, Egan J (2001) Evaluation of CMV viral load using TaqMan CMV quantitative PCR and comparison with CMV antigenemia in heart and lung transplant recipients. Transplant 71:1609-1615
42. Drew WL (2007) Laboratory diagnosis of cytomegalovirus infection and disease in immunocompromised patients. Curr Opin Infect Dis 20:408-411
43. Lengerke C, Ljubicic T, Meisner C et al (2006) Evaluation of the COBAS Amplicor HCMV Monitor for early detection and monitoring of human cytomegalovirus infection after allogenic stem cell transplantation. Bone Marrow Transplant 38:53-60
44. Allice T, Enrietto M, Pittaluga F et al (2006) Quantitation of cytomegalovirus DNA by real-time polymerase chain reaction in peripheral blood specimens of patients with solid organ transplants: comparison with end-point PCR and pp65 antigen test. J Med Virol 78:915-922
45. Pumannova M, Roubalova K, Vitek A, Sajdova J (2006) Comparison of quantitative competitive polymerase chain reaction- enzyme-linked immunosorbent assay with LightCycler-based polymerase chain reaction for measuring cytomegalovirus DNA in patients after hematopoietic stem cell transplantation. Diagn Microbiol Infect Dis 54:115-120
46. Mori T, Mori S, Kanda Y et al (2004) Clinical significance of cytomegalovirus (CMV) antigenemia in the prediction and diagnosis of CMV gastrointestinal disease after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 33:431 - 434
47. Weinberg A, Hodge TN, Li S et al (2000) Comparison of PCR, antigenemia assay, and rapid blood culture for detection and prevention of cytomegalovirus disease after lung transplantation. J Clin Microbiol 38(2):768-772
48. Ikewaki J, Ohtsuka E, Kawano R et al (2003) Real-time PCR assay compared to nested PCR and antigenemia assays for detecting cytomegalovirus reactivation in adult T-cell leukemia- lymphoma patients. J Clin Microbiol 41:4382-4387